CMKLR1 and pulmonary fibrosis: Consequently, the application of CMKLR1-targeted PET may extend beyond pulmonary fibrosis to various inflammatory lung diseases; hence, it is imperative to consider the unique context of the underlying disease for a better understanding of the implications of the uptake of CMKLR1-targeting tracers.